PubMed

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.

Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S.

Ann Intern Med. 2005 Dec 20;143(12):857-69.PMID: 16365467 [PubMed - indexed for MEDLINE]Related articlesFree article

High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis.

Chen H, Suda KJ, Turpin RS, Pai MP, Bearden DT, Garey KW.

Curr Med Res Opin. 2007 May;23(5):1057-65.PMID: 17519072 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.

Zilberberg MD, Kothari S, Shorr AF.

Crit Care. 2009;13(3):R94. Epub 2009 Jun 19.PMID: 19545361 [PubMed - indexed for MEDLINE]Related articlesFree article

Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.

Wingard JR, Wood CA, Sullivan E, Berger ML, Gerth WC, Mansley EC.

Clin Ther. 2005 Jun;27(6):960-9.PMID: 16117996 [PubMed - indexed for MEDLINE]Related articles

Management of systemic candidal infections in the intensive care unit.

Kam LW, Lin JD.

Am J Health Syst Pharm. 2002 Jan 1;59(1):33-41. Review.PMID: 11813465 [PubMed - indexed for MEDLINE]Related articles

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O; AmarCand Study Group.

Crit Care Med. 2009 May;37(5):1612-8.PMID: 19325476 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.

Sohn HS, Lee TJ, Kim J, Kim D.

Clin Ther. 2009 May;31(5):1105-15; discussion 1066-8.PMID: 19539111 [PubMed - indexed for MEDLINE]Related articles

Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.

DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA.

J Crit Care. 2007 Sep;22(3):237-44. Epub 2007 Apr 10.PMID: 17869975 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.

Nomura K, Kawasugi K, Morimoto T.

Eur J Cancer Care (Engl). 2006 Mar;15(1):44-50.PMID: 16441676 [PubMed - indexed for MEDLINE]Related articles

Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.

Girão E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EA, Costa SF.

Med Mycol. 2008 Sep;46(6):581-8.PMID: 19180727 [PubMed - indexed for MEDLINE]Related articles

Caspofungin therapy of neonates with invasive candidiasis.

Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B, Sàenz A, Herrera ML, Walsh TJ.

Pediatr Infect Dis J. 2004 Dec;23(12):1093-7.PMID: 15626944 [PubMed - indexed for MEDLINE]Related articles

Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.

Nolla-Salas J, Sitges-Serra A, León-Gil C, Martínez-González J, León-Regidor MA, Ibáñez-Lucía P, Torres-Rodríguez JM.

Intensive Care Med. 1997 Jan;23(1):23-30.PMID: 9037636 [PubMed - indexed for MEDLINE]Related articles

Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.

Wingard JR, Leather HL, Wood CA, Gerth WC, Lupinacci RJ, Berger ML, Mansley EC.

Am J Health Syst Pharm. 2007 Mar 15;64(6):637-43.PMID: 17353573 [PubMed - indexed for MEDLINE]Related articles

Esophageal candidiasis in patients infected with the human immunodeficiency virus. A decision analysis to assess cost-effectiveness of alternative management strategies.

Rabeneck L, Laine L.

Arch Intern Med. 1994 Dec 12-26;154(23):2705-10.PMID: 7993154 [PubMed - indexed for MEDLINE]Related articles

Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis.

Neuner JM, Hamel MB, Phillips RS, Bona K, Aronson MD.

Ann Intern Med. 2003 Jul 15;139(2):113-22.PMID: 12859161 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.

McGee WT, Tereso GJ.

Crit Care Med. 2003 May;31(5):1577-8.PMID: 12771636 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia.

Rosen AB, Fowler VG Jr, Corey GR, Downs SM, Biddle AK, Li J, Jollis JG.

Ann Intern Med. 1999 May 18;130(10):810-20.PMID: 10366370 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.

Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL.

J Antimicrob Chemother. 2007 Aug;60(2):385-93. Epub 2007 Jun 7.PMID: 17561501 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of invasive candidiasis in critically ill patients.

Blot S, Vandewoude K.

Drugs. 2004;64(19):2159-75. Review.PMID: 15456333 [PubMed - indexed for MEDLINE]Related articles

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

Schuster MG, Edwards JE Jr, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, Slotman G, Panzer H, Biswas P, Rex JH.

Ann Intern Med. 2008 Jul 15;149(2):83-90.PMID: 18626047 [PubMed - indexed for MEDLINE]Related articlesFree article